<PAGE>218

## 참고 문헌

1.  Muller LMAJ, Gorter KJ, Hak E, et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis 2005;41: 281-8.
2.  Groenwold RHH, Hoes AW, Hak E. Impact of influenza vaccination on mortality risk among the elderly. Eur Respir J 2009;34:56-62.
3.  Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl Med 2009;361: 1935-44.
4.  Campbell A, Rodin R, Kropp R, et al. Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza. CMAJ 2010;182:349-55.
5.  Allard R, Tremblay C, LeClerc P, Tannenbaum T. Diabetes and the severity of pandemic influenza A (H1N1) infection. Diabetes Care 2010;33:1491-3.
6.  Nichol KL, Nordin JD, Nelson DB, et al. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 2007;357:1373-81.
7.  Looijmans-Van Den Akker I, Nichol KL, Verheij TJM, et al. Clinical effectiveness of first and repeat influenza vaccination in adult and elderly diabetic patients. Diabetes Care 2006;29:1771-6.
8.  Kornum J, Lervang H-H, Thomsen RW, et al. Diabetes, glycemic control, and risk of hospitalization with pneumonia. Diabetes Care 2008;31:1541-5.
9.  Fisman D, Abrutyn E, Spaude K, et al. Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community acquired pneumonia. Clin Infect Dis 2006;42:1093-101.